Long-term Safety and Efficacy of ABP 501 in Subjects With Moderate to Severe Rheumatoid Arthritis

Clinical trial NCT02114931 · COMPLETED

Trial details

NCT number: NCT02114931
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2014-04-01
Primary completion: 2016-04-01
Enrollment: 467

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.